Best Healthcare Market Research Companies in Lebanon (2026 Guide)
An independent guide to the leading healthcare market research companies operating in Lebanon for 2026. This guide profiles 5 specialist and full-service firms covering pharmaceutical U&A, physician surveys, KOL mapping at the American University of Beirut Medical Center (AUBMC) and LAU Medical Center-Rizk Hospital, Ministry of Public Health Lebanon (MoPH Lebanon) regulatory awareness, and trilingual French-Arabic-English research — comparing capabilities and Lebanon-specific healthcare expertise to help you select the right research partner in this historically sophisticated pharmaceutical distribution market and regional Levant healthcare intelligence hub.
Published 2026-06-11 · By BioNixus Research Team
5
Firms Profiled
Pharma
Heritage Market
AUBMC
+ LAU Medical
8
FAQs Answered
Best Healthcare Market Research Companies in Lebanon (2026)
The following healthcare market research companies have demonstrated operations or project delivery in Lebanon as of 2026, covering pharmaceutical research, physician studies, KOL mapping at AUBMC and LAU Medical, MoPH Lebanon regulatory research, and trilingual fieldwork:
- 1BioNixus — Best for: pharmaceutical U&A, KOL mapping at AUBMC and LAU Medical, MoPH Lebanon regulatory awareness, trilingual French-Arabic-English research, Levant physician networks
- 2IQVIA MENA — Best for: Lebanon pharma data via regional network, Levant pharmaceutical analytics, secondary market data
- 3Ipsos Healthcare — Best for: Lebanon healthcare research, quantitative physician surveys, consumer health studies
- 4Kantar Health — Best for: patient and consumer health research, OTC brand tracking, treatment decision studies
- 5Euromonitor International — Best for: OTC healthcare market sizing, consumer health syndicated data, Lebanon country reports, competitive landscape intelligence
Lebanon Healthcare Market Research Landscape 2026
Lebanon holds a distinctive position in the MENA pharmaceutical and healthcare landscape: a market defined by historically strong private healthcare infrastructure, a world-class academic medical tradition anchored at the American University of Beirut Medical Center (AUBMC), and a sophisticated pharmaceutical distribution culture built over decades. The Ministry of Public Health Lebanon (MoPH Lebanon) oversees pharmaceutical registration, drug pricing policy, and healthcare system regulation, maintaining an active regulatory framework even amid the broader economic challenges facing Lebanon. The Ordre des Médecins du Liban (OML — Lebanese Medical Order) provides the professional regulatory framework for physician practice, and its networks are essential for compliant healthcare professional engagement in research.
Lebanon's academic medical institutions — particularly AUBMC and LAU Medical Center-Rizk Hospital (affiliated with the Lebanese American University School of Medicine) — are among the most internationally recognised in the Arab world, publishing significantly in international medical literature and hosting senior KOLs who influence Levant-wide clinical practice. For pharmaceutical companies launching in Lebanon or seeking Levant-wide KOL insights, AUBMC and LAU Medical physician networks provide access to Arabic-English-French trilingual specialists across oncology, cardiology, endocrinology, infectious disease, and primary care. Lebanon's trilingual healthcare culture — operating across French, Arabic, and English — creates a unique research complexity that requires specialist multilingual instrument design and fieldwork management.
Despite Lebanon's economic challenges since 2019, the pharmaceutical market retains structural significance: Lebanon has a long-established generic pharmaceutical manufacturing capacity, a strong tradition of pharmaceutical export to the Levant and Gulf, and a physician community that continues to function as influential regional thought leaders. The post-crisis healthcare landscape has also created new research questions around healthcare access, supply chain resilience, and health insurance coverage gaps that are relevant to pharmaceutical market access and policy research. Companies seeking Levant-wide healthcare intelligence consistently include Lebanon for the quality of its physician and academic networks, even as the market's commercial size has contracted.
5 Healthcare Market Research Companies in Lebanon (2026)
Firms are assessed by use case and market positioning — select based on your research type, sector, and in-country requirements.
BioNixus
Best for: pharmaceutical U&A, KOL mapping at AUBMC and LAU Medical, MoPH Lebanon regulatory awareness, trilingual French-Arabic-English research, Levant physician networks
BioNixus is a global healthcare and market research firm headquartered in the USA with offices in the UK and the Middle East, delivering specialist pharmaceutical and healthcare research across Lebanon and the wider Levant. With 15+ years of experience serving 48+ global clients across 17+ countries, BioNixus covers the full healthcare research value chain: pharmaceutical usage and attitude (U&A) studies, brand perception and positioning, physician surveys across specialty and primary care, Key Opinion Leader (KOL) mapping and engagement profiling at AUBMC and LAU Medical Center-Rizk Hospital, payer and formulary research, Health Economics and Outcomes Research (HEOR), and market access strategy. BioNixus operates with awareness of MoPH Lebanon registration and regulatory frameworks, the Ordre des Médecins du Liban's professional standards, and Lebanon's trilingual French-Arabic-English medical community. As a global firm comparable in scope to IQVIA and Kantar Health, BioNixus delivers decision-ready pharmaceutical research to multinational pharma, biotech, and medical device clients targeting Lebanon, the Levant, and the broader MENA market.
Key strengths
- Pharmaceutical U&A, brand tracking, and therapy area landscaping in Lebanon
- Physician and specialist recruitment within AUBMC, LAU Medical, and Beirut hospital networks
- KOL mapping and stakeholder engagement profiling across Lebanon therapy areas
- MoPH Lebanon regulatory framework awareness and OML-aligned research protocols
- Trilingual French-Arabic-English instrument design and fieldwork execution
- HEOR and market access strategy for MoPH Lebanon formulary submissions
- Post-crisis healthcare landscape and supply chain resilience research
- Levant-wide regional pharmaceutical intelligence incorporating Lebanon physician networks
IQVIA MENA
Best for: Lebanon pharma data via regional network, Levant pharmaceutical analytics, secondary market data
IQVIA is the world's largest healthcare data and analytics company, serving Lebanon through its MENA regional network. In Lebanon, IQVIA provides pharmaceutical market data, secondary analytics, regulatory intelligence, and commercial consulting for pharmaceutical manufacturers operating in the Levant. Given Lebanon's economic environment, IQVIA's Lebanon operations are typically delivered through its broader Levant and MENA regional framework rather than a dedicated Lebanon office, focusing on data analytics and commercial strategy rather than bespoke primary research. IQVIA is the default choice for companies requiring historical pharmaceutical market trend data and Levant-wide secondary analytics.
Key strengths
- Pharmaceutical market data and audit for Lebanon via regional Levant network
- Secondary data analytics and market share trend analysis
- Levant-wide regulatory intelligence and commercial consulting
- Real-world evidence design for Levant multi-country studies
- Sales force effectiveness and commercial analytics
Ipsos Healthcare
Best for: Lebanon healthcare research, quantitative physician surveys, consumer health studies
Ipsos has historically maintained a presence in Lebanon through its Beirut office, giving it a degree of direct market access for healthcare research in the country. Ipsos Healthcare provides quantitative physician surveys, patient satisfaction research, and consumer health studies in Lebanon, leveraging Arabic and French language fieldwork capabilities. While Ipsos delivers solid quantitative healthcare research coverage, its specialist depth in MoPH Lebanon regulatory research, AUBMC and LAU Medical KOL mapping, and payer committee engagement is more limited than dedicated pharmaceutical research firms with established Lebanon healthcare networks.
Key strengths
- Quantitative physician and consumer health surveys in Lebanon
- Arabic and French language fieldwork execution
- Patient satisfaction and healthcare experience research
- Lebanon direct market presence and field infrastructure
- MENA-wide sample and benchmarking capabilities
Kantar Health
Best for: patient and consumer health research, OTC brand tracking, treatment decision studies
Kantar's healthcare practice serves Lebanon through its MENA regional hub, focusing on the consumer health and patient experience segments. For pharmaceutical clients in Lebanon, Kantar Health provides brand health tracking, treatment decision studies, and patient journey research across chronic disease categories. Their quantitative survey infrastructure and MENA panel access make them a capable partner for large-scale consumer health studies, though bespoke AUBMC or LAU Medical physician recruitment and MoPH Lebanon-aligned payer research fall outside their primary capabilities.
Key strengths
- Consumer health tracking and OTC brand research in Lebanon
- Patient experience and treatment decision studies
- Large-scale quantitative health behaviour surveys
- Brand health tracking across chronic disease categories
- MENA-wide panel and sample infrastructure
Euromonitor International
Best for: OTC healthcare market sizing, consumer health syndicated data, Lebanon country reports, competitive landscape intelligence
Euromonitor International provides syndicated healthcare and consumer health market intelligence for Lebanon through its Passport database. Their coverage spans OTC medications, dietary supplements, consumer medical devices, and personal care/health categories with trend analysis and competitive brand share data. Euromonitor does not conduct custom primary research, physician surveys, or qualitative KOL studies — their value is standardised market sizing data for category benchmarking, market entry assessment, and Lebanon country health reports. Given Lebanon's dynamic economic context, Euromonitor's syndicated data should be validated against more recent primary research where investment decisions depend on it.
Key strengths
- Syndicated OTC healthcare and consumer health market data for Lebanon
- Category trend analysis and competitive brand share profiling
- Lebanon country health reports and MENA benchmarking
- Market entry assessment and category sizing data
Lebanon Healthcare Market Research Capabilities Comparison
| Capability | BioNixus | IQVIA MENA | Ipsos Healthcare | Kantar Health | Euromonitor |
|---|---|---|---|---|---|
| Pharmaceutical primary research (U&A) | Core capability | Limited — analytics-led | Quantitative focus | Consumer health focus | None (syndicated only) |
| Physician / KOL recruitment (AUBMC / LAU) | Yes — specialist networks | Regional data only | Limited | Limited | No |
| MoPH Lebanon regulatory support | Awareness & alignment | Regulatory intelligence | Partial | Partial | No |
| Real-world evidence (RWE) | Custom design | Core capability | Limited | Limited | No |
| Payer / formulary research | Yes — MoPH Lebanon aligned | Regulatory intelligence | Limited | Limited | No |
| Trilingual (French / Arabic / English) | Yes — full capability | Partial | Arabic / French | Arabic / English | English reports only |
Key Considerations for Healthcare Market Research in Lebanon
MoPH Lebanon Regulatory Framework and OML Standards
The Ministry of Public Health Lebanon (MoPH Lebanon) maintains an active pharmaceutical registration and healthcare regulation framework despite Lebanon's broader economic challenges. Pharmaceutical research generating evidence for MoPH drug registration, pricing submissions, or formulary inclusion must be designed in compliance with MoPH Lebanon requirements. The Ordre des Médecins du Liban (OML) provides the professional regulatory framework for physician practice — any research engaging Lebanese healthcare professionals must respect OML standards on research ethics and professional engagement. A research partner with MoPH Lebanon and OML familiarity significantly reduces compliance risk in primary research execution.
AUBMC and LAU Medical KOL Access
Lebanon's premier academic medical institutions — AUBMC and LAU Medical Center-Rizk Hospital — host the country's most influential clinical KOLs, whose research contributions and clinical leadership extend across the Levant and Arab world. For pharmaceutical companies, engaging AUBMC and LAU Medical faculty for advisory boards, clinical insights, or KOL mapping provides access to opinion leaders with disproportionate regional influence. Research conducted with AUBMC and LAU Medical networks must comply with institutional IRB requirements and the American University of Beirut's research ethics policies, which are modelled on US academic research standards.
Lebanon's Pharmaceutical Culture and Post-Crisis Research Opportunity
Lebanon has historically been one of the most sophisticated pharmaceutical markets in the Arab world, with a strong tradition of drug distribution, generic manufacturing, and pharmaceutical export to the Levant and Gulf. Despite the economic crisis, Lebanon's physician community remains highly educated, internationally connected, and active in clinical research. This creates a valuable primary research asset: Lebanese physicians can provide insights on comparative therapy standards, regional prescribing trends, and drug access challenges that are uniquely valuable for Levant-wide market strategy. Studies that contextualise Lebanon's post-crisis healthcare landscape within regional pharmaceutical strategy deliver substantially richer intelligence than purely commercial data reviews.
Frequently Asked Questions
What are the best healthcare market research companies in Lebanon?
Leading healthcare market research companies serving Lebanon include BioNixus, IQVIA MENA, Ipsos Healthcare, Kantar Health, and Euromonitor International. BioNixus is a global healthcare and market research firm with Lebanon and Levant execution capability covering pharmaceutical U&A, physician surveys and KOL mapping at AUBMC and LAU Medical, MoPH Lebanon regulatory awareness, and trilingual French-Arabic-English research.
How much does pharmaceutical market research cost in Lebanon?
Custom pharmaceutical market research in Lebanon typically ranges from $15,000 to $60,000 per project depending on scope, methodology, and sample requirements. Given Lebanon's current economic environment, fieldwork logistics and respondent incentivisation may require careful planning. KOL mapping studies with AUBMC and LAU Medical faculty recruitment tend to command a premium. Syndicated reports from providers such as Euromonitor start from around $2,500.
How do I recruit physicians at AUBMC for market research?
Physician recruitment within AUBMC requires established professional relationships and, for formal research, institutional IRB approval from AUB's research ethics committee. BioNixus maintains Lebanon and Levant physician networks that include AUBMC faculty and specialists across oncology, cardiology, endocrinology, and other therapy areas, as well as LAU Medical Center-Rizk Hospital professionals, enabling compliant physician survey and KOL mapping engagements in Lebanon.
What is MoPH Lebanon and how does it regulate pharmaceuticals?
The Ministry of Public Health Lebanon (MoPH Lebanon) is Lebanon's primary authority for pharmaceutical regulation, drug registration, drug pricing policy, and healthcare system oversight. MoPH Lebanon maintains an active regulatory framework including requirements for clinical trial authorisation and pharmacovigilance. The Ordre des Médecins du Liban (OML) provides the professional standards framework for physician practice and research ethics, and should be taken into account in any primary research design involving Lebanese healthcare professionals.
Why is Lebanon important for Levant healthcare research?
Lebanon's AUBMC and LAU Medical institutions are among the most internationally recognised academic medical centres in the Arab world, hosting senior KOLs whose influence extends across the Levant, Gulf, and global Arabic-speaking medical communities. Despite the economic crisis, Lebanese physicians remain highly educated, internationally connected, and active in clinical research — making Lebanon a critical source of regional pharmaceutical insights. Companies seeking Levant-wide healthcare intelligence consistently include Lebanon for the quality and regional reach of its physician and academic networks.
What is the trilingual research challenge in Lebanon?
Lebanon's medical culture operates across three languages — French, Arabic, and English — reflecting the historical influence of French medical education at Saint-Joseph University (USJ) and Francophone institutions alongside the Anglophone tradition at AUB and LAU. Survey instruments, discussion guides, and research materials must be adapted across all three languages, with attention to medical terminology differences across French- and English-trained physician cohorts. A research partner experienced in trilingual Lebanese fieldwork significantly improves data quality and respondent engagement.
What is KOL mapping and why is it important in Lebanon?
Key Opinion Leader (KOL) mapping identifies the most influential physicians, academics, and healthcare decision-makers in a therapy area. In Lebanon, KOL mapping is particularly important because AUBMC and LAU Medical concentrate physicians who publish in international journals, present at global congresses, and shape prescribing practices across Lebanon, the Levant, and the broader Arab world. Lebanese KOLs often hold regional influence disproportionate to the domestic market size, making Lebanon KOL mapping a high-value component of Levant-wide pharmaceutical strategy.
Does BioNixus conduct healthcare market research in Lebanon?
Yes. BioNixus is a global healthcare and market research firm with Lebanon and Levant execution capability, serving pharmaceutical, biotech, and medical device clients in Lebanon. We cover pharmaceutical U&A, physician surveys, KOL mapping at AUBMC and LAU Medical, payer and formulary research, HEOR, market access strategy, and trilingual French-Arabic-English fieldwork — all designed with MoPH Lebanon regulatory awareness. Contact us to discuss your Lebanon healthcare research requirements.
Plan Healthcare Market Research in Lebanon
BioNixus delivers custom healthcare and pharmaceutical market research across Lebanon and the wider Levant — physician surveys, KOL mapping at AUBMC and LAU Medical, payer research, HEOR, MoPH Lebanon regulatory awareness, and trilingual French-Arabic-English fieldwork.
Request a Proposal